Print Page   |   Sign In   |   Register
Companies: Avita Medical Ltd. (AVMXY)

Company Profile

Description

Avita Medical develops and distributes regenerative products for the treatment of a broad range of wounds, scars and skin defects. Avita's patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient's own skin. The Company's lead product, ReCell, is used in the treatment of a wide variety of burns, plastic, reconstructive and cosmetic procedures. ReCell is patented, CE marked for Europe, TGA registered in Australia, and CFDA cleared in China. In the United States, ReCell is an investigational device limited by federal law to investigational use. A pivotal U.S. trial is underway, with patient enrollment completion anticipated by the end of 2015.

Contact Info

  • 9221 Corbin Avenue
  • Suite 220
  • Northridge, CA 91324

   

Financial Reporting/Disclosure

Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Jun 30, 2016 Quarterly Report
CIK 0001541697
Fiscal Year End 6/30
OTC Marketplace OTCQX International

Profile Data

SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: Australia
Year of Inc. 2008
Employees 33 a/o Sep 19, 2016

Company Officers/Contacts

Adam Kelliher CEO
Troy Barring COO
Timothy Rooney CFO, COO

Company Directors

Lou Panaccio Chairman
Jeremy Curnock Cook Non-Executive Director
Suzanne Crowe Non-Executive Director
Michael Perry Non-Executive Director
Louis Drapeau Non-Executive Director

Company Notes

  • Formerly=Clinical Cell Culture, Ltd. until 5-2009
  • Formerly=Ecat Development Capital Ltd. until 9-03

Service Providers

OTCQX Advisor
MCAP LLC
1633 Broadway 28th Floor
New York, NY, 10019
USA

Accounting/Auditing Firm
Grant Thornton
Level 1
10 Kings Park Road
West Perth, WA, 6005
Australia

Legal Counsel
Steinepreis Paganin Lawyers & Consultants
Level 4, The Read Buildings
16 Milligan Street
Perth, WA, 6000
Australia

Clifford Chance
31W 52nd Street
New York, NY, 10019
United States

Investor Relations Firm
Not Available

 

 
Community Search
Sign In